ENDURANCE TRAINING OFTEN LEADS to hemodilution, with the phenomenon of "sports anemia" frequently reported in elite athletic populations (11) . Multiple days of intense exercise, such as that required for multistage cycling racing, serve to further exacerbate such hemodilution (12, 13) . To date, there are a number of published studies that document changes in hematological variables such as hemoglobin concentration ([Hb] ), hematocrit (Hct), percentage of reticulocytes (%Ret-ics), and more recently, hemoglobin mass (Hbmass) during cycling stage races of 1-3 wk. In the largest cohort currently investigated, Lombardi et al. (30) report decreased [Hb] and Hct values during the first half of a 10-day cycling race. Similar findings have been reported by others, albeit in much smaller cohorts (15, 31, 40) . The reduction in [Hb] and Hct has been attributed to plasma volume (PV) expansion induced by the intensity of the race (21) , since Hbmass remains stable (15, 40) .
Cycling is a global sport with races performed all over the world. It is not uncommon for races to be held in challenging environments, both in terms of climate (hot and cold) and terrain (altitude). All three "Grand Tours" (the most popular stage races, Tour de France, Giro d'Italia, and Vuelta a Espana) typically involve several days racing at low to moderate altitude (4) in the Alps or Pyrenees, although the time spent at altitude is usually limited to 3-4 days at any one time and with nightly accommodation usually at lower altitudes. Altitude training itself is a popular training tool utilized by many cyclists as a legal mean of increasing Hbmass (23) . It is well documented that altitude exposure acutely decreases PV to rapidly increase [Hb] (42) , and thereby arterial oxygen content, before longer term adaptive mechanisms (5) . If the total dose of exposure is sufficiently long and high enough, then accelerated erythropoiesis may result in an increase in Hbmass (38) . At least 7 days of exposure are required before a marginal Hbmass response may be observed (23) , although the response to exposures of 3-4 wk is more commonly reported (49) .
A number of cycling races on the International Cycling Union (UCI) calendar are held entirely at altitude. The effect of such races, where both the racing itself (hemodilution) and the hypoxic environment (hemoconcentration) will exert opposing stimuli on the hematological profile of the cyclists and the distribution of their blood compartments, has yet to be evaluated. The Tour of Qinghai Lake is considered one of the highest elevation cycling stage races in the world, with the first 8 days held at altitudes between 2,000 and 4,000 m, and at almost 2 wk in duration, the hypoxic dose is potentially sufficient to induce increases in Hbmass. The aim of the present study was to quantify the hematological and physiological responses of unacclimated sea-level residents during a cycling stage race at altitude and to compare them with responses observed under similar physiological demands at sea level. The response of long-term altitude resident cyclists during racing at altitude was also examined since this group provides a reference point for lifetime adaptation to the altitude stimulus. We hypothesized that the magnitude of PV expansion observed in sea-level residents racing at altitude would be blunted compared with the long-term altitude residents due to the acute demand to enhance oxygen delivery of the sea-level residents at altitude.
MATERIALS AND METHODS
Study design. Four teams participating in the 2013 Tour of Qinghai Lake agreed to participate in the study that was approved by the Australian Institute of Sport Human Ethics Committee (Canberra, Australia), the Shaffalah Medical Genetics Center Ethics Committee (Doha, Qatar), and the Qinghai Province Sports Science Research Laboratory Ethics Committee (Duoba, China). All cyclists provided written informed consent before the start of the study. In the absence of a comparable race at sea level, two of the four teams participated in a simulation of the Tour of Qinghai Lake at low altitude during the month before the race in China. These teams served to provide information on the effect of intense exercise alone in the absence of hypoxia. The 2013 edition of the Tour of Qinghai Lake (7th-20th July, China) consisted of 13 stages with 1 rest day. The race was sanctioned by the UCI as a 2.HC (hors category) race, the highest level race below the "World Tour," and was open to UCI Pro Tour, UCI Professional Continental, and UCI Continental and National cycling teams. In 2013, the race covered 2,002 km with an average altitude of 2,496 m. Details of each stage as well as a timeline of all measurements are summarized in Table 1 .
Subjects. The teams studied comprised two Chinese (CHN) "Continental" teams and two Australian (AUS) teams (1 Continental and 1 National team). Rider characteristics can be found in Table 2 . The Chinese riders were predominantly of Han Chinese origin born between 1,500 and 3,500 m and resided in the Qinghai (ϳ2,300 -3,500 m) or Gansu (ϳ1,600 m) Provinces when not competing (Table  2) . Both Chinese teams arrived in Duoba (the location of the first stage at an altitude of 2,388 m) 10 days before the start of the race. The Australian riders were Caucasian sea-level residents and were not acclimatized to altitude before the race, arriving in Duoba 3-5 days before the first stage. Further, the Australian riders had not completed any altitude training for at least 3 mo before the start of the study, with only one rider having competed in a previous edition of the race. Each team began the race with seven riders. One of the Chinese teams included three European riders who were excluded from the study. Riders who did not complete a stage within the allotted time or who could not continue due to illness or injury were withdrawn from the race. Both Australian teams were screened for iron deficiency before departure for China, with all riders iron replete. All Australian riders were supplemented with oral iron (305 mg ferrous sulphate ϩ 1,000 mg vitamin C) on a daily basis for the duration of their stay in China. Simulated tour at low altitude. One month before the race, 12 Australian riders (SIM) completed a simulation of the first seven stages of the Tour of Qinghai Lake at low altitude (580 m, Canberra, Australia) to provide a reference for the response to racing alone. Characteristics of each stage (e.g., distance, meters of climbing) were simulated where possible, as well as possible race scenarios (e.g., breakaways, intermediate sprints) to increase overall intensity. A total of 1,090 km and ϳ10,400 m of climbing were covered in the seven simulated stages in Canberra, compared with 1,154 km and ϳ9,750 m of climbing during stages 1-7 in China. Due to injury, two cyclists who participated in the simulated tour were unable to travel to China and were replaced by reserves.
Hematology. During the simulated tour, venous blood samples were obtained in the morning before the first "stage" and on day 5 (after 4 "stages") and day 9 (after 8 "stages"). In China, venous blood was drawn on five occasions from the Australian riders: 1 day before the race start (D-1) and before the 3rd (D3), 6th (D6), 9th (D10), and 14th (D14) stages. Three blood collections were performed on the Chinese riders: 1 day before the start of the race (D-1) and on the rest day (D9) and the morning after the race had finished (D15). All blood sampling, handling, and transport, both in Australia and China, were performed in strict accordance with World Anti-Doping Agency (WADA) and UCI rules (44) to ensure consistency and reliability (30) . Specifically, all blood tests were performed at rest between 0600 and 0900 without prior exercise and with cyclists seated for at least 10 min before collection with their feet on the floor (1) . No restrictions for prior food consumption were enforced, since this is not controlled under WADA or UCI rules for sampling. Blood was collected into a 3.5-ml evacuated K 2EDTA-coated tube and inverted at least 10 times. In Australia, blood was analyzed within 30 min onsite at the Australian Institute of Sport. In China, blood was stored and transported by car to the Chinese Laboratory (Qinghai Affiliated University Hospital, Xining, China) inside a portable refrigeration device (part no. 85401; NanoCool, Albuquerque, NM) and analyzed within 36 h of collection (usually within 12 h) as per WADA guidelines (44) . The temperature of the storage device was logged throughout transport using a silicon chip data logger (iButton, part no. DS1922L#F50; Maxim Integrated Products, San Jose, CA).
In both laboratories analysis was performed using a Sysmex XE 2100 (Sysmex, Kobe, Japan) using "automatic" mode. In accordance with UCI and WADA guidelines, each sample was analyzed at least twice and repeated if values for [Hb] and %Retic were not within acceptable limits (43) . However, in the case that the second sample was within tolerance of the first, the first values were used.
All cyclists participating in the Tour of Qinghai Lake were required to present for in-competition antidoping controls performed by UCI officials if called upon. During the Tour, three riders involved in the study were selected at random for such controls. It is assumed, but cannot be fully excluded, that none of the riders who participated in the present study took any performance enhancing substance, including erythropoietic simulating agents or undertook any illegal doping practices before or throughout the study period due to the close observation of the research team.
Hbmass. Hbmass was assessed via carbon monoxide rebreathing (35, 39) before and after the simulated tour in Australia, 2-3 days before the start of the race in China, after the 8th stage (AUS) or on the rest day (CHN), and after the 12th (CHN) and 13th (AUS) stages. Briefly, a 99.99% chemically pure CO bolus was rebreathed with 100% pure oxygen through a glass spirometer for 2 min. At low altitude (Canberra, Australia), the CO bolus administered was equivalent to 1.2 ml/kg. At higher altitudes, the volume of CO administered was adjusted in accordance with changes in barometric pressure such that larger volumes were administered at higher altitudes to keep the molar volume of CO administered constant. HbCO of capillary blood was measured in five replicates before and 7 min after inhalation. The typical error of the CO rebreathing method, assessed from duplicate measures performed during the simulated tour in Canberra, was 1.3% (90% confidence limits: 1.0 -2.0%). The same researcher performed all tests in both Australia and China. All necessary equipment, including the CO-oximeter (OSM3; Radiometer, Copenhagen, Denmark), was transported from Australia and used throughout the race to ensure continuity between tests.
Wellness monitoring and altitude sickness. In China, body mass (UC-321; A&D Weighing, SA, Australia), resting heart rate and oxygen saturation (SpO2; both via pulse oximetry; Onyx Vantage 9590; Nonin Medical), and urine specific gravity (PEN Urine SG refractometer 3741; Atago, Tokyo, Japan) of the Australian riders were assessed daily before breakfast. In addition, riders were asked to complete the Lake Louise Questionnaire for Assessment of Acute Mountain Sickness (37) as well as a wellness questionnaire consisting of five questions relating to fatigue, soreness, sleep, stress levels, and overall mood (6) . An overall wellness score was created from the sum of each component with a total possible score of 25, with higher overall wellness scores associated with more positive ratings of well-being (6) .
Statistical analysis and data treatment. PV was calculated using Hbmass, [Hb] , and Hct, and total blood volume (TBV) according to the following formula:
Hb mass ͑g͒ ϭ ͓Hb͔͑g ⁄ l͒ ϫ TBV͑l͒ TBV ϭ Hb mass ⁄ ͓Hb͔ TBVx͑1 Ϫ Hct͒ ϭ PV The percent change in PV was calculated as follows:
where PV post is the PV calculated during the race and PVpre is the PV calculated before the start of the race. Baseline values for Hbmass were used to calculate PV at days 3 and 6, with corresponding Hbmass values used at days 9 and 14.
Separate repeated-measures ANOVAs with main effects of group (SIM, AUS, and CHN) and time (day of race) were used to compare the hematological responses during the race between the Australians and the Chinese riders (AUS vs. CHN), as well as between the Australians during simulated tour and the Tour of Qinghai Lake (AUS vs. SIM). Specifically, the influence of altitude vs. sea-level residence on the PV response to stage racing at altitude was assessed using a repeated-measures ANOVA with two repeated factors for altitude residence and time, while the influence of racing at altitude vs. sea-level was assessed using a repeated-measures ANOVA with repeated factors for altitude of racing and time, for data collected during the first 8 days. Tukey's honestly significant difference post hoc tests were used to identify differences between cells means. Possible differences at baseline between the AUS and CHN as well as AUS and SIM were assessed using t-tests. All analyses were completed using Statistica (Version 6.0; Statsoft, Tulsa, OK), with the level of significance set to P Յ 0.05. Values in the text and figure are reported as means Ϯ SD unless otherwise stated. Means and statistical analysis were calculated using data only from riders who completed all testing sessions; however, all individual data collected are presented in the figure.
Hematology. Before the race, Chinese riders had higher absolute Hbmass than the Australians, as well as a higher absolute and relative reticulocyte count and higher numbers of platelets (Table 3) .
During racing, [Hb] decreased significantly over time in both groups racing at altitude [F (2, 26) ϭ 27.3, P Ͻ 0.0001] as well as during the simulated tour at sea level [F (2, 38) (Table 3) .
During racing in Qinghai, %Retics increased significantly in the Australians only [time effect, AUS and CHN F (2, 26) ϭ 31.9, P Ͻ 0.0001; Fig. 1B ]. The %Retics of Australians racing at altitude were elevated at day 6 compared with prerace (P ϭ 0.02), but by the end of the race were suppressed compared with midrace (P ϭ 0.0002). In the Chinese riders, %Retics at the end of the race were lower than both pre (P ϭ 0.007)-and midrace (P ϭ 0.001). A similar pattern was observed in absolute reticulocyte numbers (Table 3) . Compared with racing at altitude, the simulated tour had no significant effects on absolute or relative reticulocyte values.
The Hbmass of the Australians increased during racing at altitude but remained stable in the Chinese riders racing at altitude and in the Australian riders during the simulated Tour at sea level (Fig. 1C) . A group by time interaction was observed between AUS and CHN, [F (2, 32) ϭ 12.9, P Ͻ 0.0001] and between AUS and SIM [F (1, 19) ϭ 20.2, P ϭ 0.0002]. Specifically, Hbmass significantly increased in AUS after 9 (P ϭ 0.0001) and 14 (P ϭ 0.008) days of racing at altitude and was lower at the end of the race than midrace (P ϭ 0.018).
PV increased in all three groups [AUS and CHN, F (2,26) ϭ 32.8, P Ͻ 0.0001; AUS and SIM, F (2,32) ϭ 23.1, P Ͻ 0001] resulting in significantly higher PVs across all time points at both sea level and altitude (Fig. 1D) . No significant interaction effects were observed, with neither altitude residence nor the altitude of racing affecting the magnitude of the increase in PV.
Wellness monitoring and altitude sickness. Overall, within the AUS group, there was a significant effect of time on body mass [F (15, 120) (15, 120) ϭ 6.7, P Ͻ 0.0001] but not waking hydration status during the Tour of Qinghai. Specifically, compared with prerace values there was a significant loss of body mass and decrease in both resting SaO 2 and well-being score, with corresponding increases in resting heart rate and Lake Louise score between stages 4 and 8 when the race passed through higher altitudes (Table 4) .
DISCUSSION
The main finding of the present study was that hemodilution was evident in both long-term altitude and sea-level residents during cycling stage racing at low to high altitude. The decrease in [Hb] can be attributed to PV expansion, which outpaced an altitude-induced increase in Hbmass in the sealevel residents. PV changes at sea-level and altitude. While acute bouts of vigorous exercise result in acute PV loss of 10 -20% (11), due to sweat loss and increases in capillary hydrostatic and tissue osmotic pressures, long-term adaptation to strenuous exercise induces a chronic PV expansion in athletes over time (24, 38) . The exact mechanism of expansion is still to be elucidated but likely involves the release of a renin, aldosterone, and vasopressin, which alter fluid and salt regulation in the kidneys (12) . The resulting conservation of water and salt, combined with the addition of albumin, alters the osmotic properties of blood and serves to increase basal plasma fluid levels.
In athletes, the phenomenon of an expanded PV has been coined "sports anemia" since the lower [Hb] often observed in athletes is an indication (and a by-product) of enhanced cardiovascular fitness as opposed to a true anemic state (48) . This notion of "sports anemia" is also supported by the measurement of Hbmass throughout similar periods, which shows that Hbmass remains stable and thus total hemoglobin has not decreased per se (15, 16) .
PV expansion and contraction occurs somewhat rapidly, with increases of up to 20% reported after just a few days of intense exercise (12); however, once the exercise stimulus is removed, PV contraction quickly returns values to basal levels (13) . Our observation of an ϳ17% increase in PV throughout the simulated tour was therefore consistent with many previous observations that intense periods of exercise have a dilutional effect even in already highly trained athletes. Indeed, hemodilution has also been observed during extended periods of competition, e.g., multiday cycling and cross country skiing competitions (12, 15, 31, 40) , with the volume and intensity of the competition correlated to the increase in PV (11) .
At altitude, the regulation is somewhat different. Maintaining oxygen delivery is a fundamental component of achieving homeostasis; thus hemoconcentration occurs rapidly upon exposure to hypoxia in response to lower arterial oxygen availability, with the decrease in PV proportional to the severity of altitude (38) . Indeed, it should be noted that the prerace [Hb] values in the Australians at altitude tended to be slightly higher (although not significant) than those observed in a similar cohort before the simulated tour near sea level and are unsurprising since the prerace sample was obtained a few days after the athletes had arrived at altitude. In the longer term, this PV contraction usually progressively resolves as Hbmass increases to improve oxygen transport.
The new feature of our study is the combination of these two stimuli: multistage racing and altitude. To our knowledge, this is the first study to assess Hb and PV changes during strenuous, Values are means Ϯ SD of Australian riders who completed the whole tour (n ϭ 9). SpO2, oxygen saturation; USG, urine specific gravity; AU, arbitrary units. *Significant difference from premeasure (Ϫ2). multiday exercise at low to high altitude. How the two types of adaptation might interact with each other was therefore unknown. With the sea-level residents already exhibiting evidence of short-term adaptation to the hypoxic environment, a logical hypothesis would be to expect an at least attenuated or even opposite response in PV during the Tour of Qinghai to meet oxygen delivery requirements. However, a marked PV expansion of ϳ17% was observed in both the sea-level and altitude residents, which began after two stages of racing in the Australians. This is very similar to data that have been reported at sea level for similar interventions (12, 32, 33, 40, 41) . It may be argued that the decrease in [Hb] observed in the Australians during the race at altitude may have been exacerbated if the prerace measures (obtained 2-4 days after arrival at ϳ2,400 m) were acutely affected by altitude exposure. However, the magnitude of decrease in [Hb] was similar between the sealevel and altitude residents and, furthermore, occurred despite an increase in Hbmass in the Australian cyclists. It is likely then that the same osmotic regulatory mechanisms responsible for PV expansion following exercise at sea level are also at play at altitude and that these supersede the drive for acute enhancement of oxygen delivery.
Consequences for cycling performance. Without doubt, the location and route of the 2013 Tour of Qinghai Lake presented a considerable physiological challenge to the athletes competing. While maximal aerobic power (V O 2max ) is by no means the sole determinant of endurance performance (10), a decrease in (V O 2max ) at altitude has been well documented (8, 27, 47) (with the decrease more marked in elite athletes compared with untrained counterparts; Ref. 20) , which also likely has consequences for athletic performance (6, 7, 42) . Since the V O 2max of athletes at sea level is limited by O 2 transport (27, 45, 46) , it could be postulated that the decrease in [Hb] observed during the race at altitude resulted in reduced O 2 delivery and would be detrimental to both V O 2max (8, 27, 47) and performance (6, 7, 42) . Alternatively, the increase in blood volume of the cyclists as a consequence of PV expansion could be beneficial, since venous return and thus stroke volume would result in an increased cardiac output for a given heart rate, thereby enhancing oxygen delivery to working muscles despite a decrease in hemoglobin per unit of blood (11) . However, when the factors determining V O 2max at sea level and altitude are modeled (46) , it becomes evident that oxygen transport is just one component of an integrated pathway. At moderate to high altitude, alterations to cardiac output and [Hb] have a relatively small impact on V O 2max (34, 46) , whereas muscle and lung oxygen diffusion capacities become of increasing importance due to the reduction in pressure gradients at these sites (45, 46) . Thus it would appear that the decrease in [Hb] observed in both the sea-level and altitude residents during the tour is unlikely to have had a substantial negative effect on overall cycling performance, with other physiological factors such as ventilation (46) and arterial oxyhemoglobin desaturation (7) likely also contributing to any decline in overall cycling ability.
Changes in Hbmass. Previous measurements performed during cycling stage races have indicated that Hbmass remains stable through periods of intense exercise (15, 40) . These data have been collected at races of ϳ1 wk in duration near sea level. This is the first study to our knowledge to measure Hbmass during a stage race at moderate altitude. The organization of the stages at the 2013 Tour of Qinghai Lake was distinctly divided into a "race of two halves"; the first eight stages being predominantly hilly/mountainous and featuring nightly altitudes above 2,200 m (3 nights above 3,000 m) until descending to 1,470 m for the rest day. We have previously observed increases in Hbmass in U23 road cyclists after 10 days of natural altitude training at 2,760 m, providing evidence that the Hbmass response to altitude may be faster than typically believed (14) . Indeed, a recent meta-analysis of Hbmass changes in response to a variety of altitude training models indicates an expected increase of 1.1% per 100 h of exposure (23) . Prerace Hbmass measurements were performed 2 days before the race start, thus creating a hypoxic dose of ϳ10 days ϫ 24 h per day ϭ 240 h. The mean Hbmass response observed in the Australians after eight stages was somewhat higher than the 2.4% predicted by the meta analysis of Gore et al. (23); however, the severity of altitude experienced on stages 3-7 serves to increase the overall hypoxic dose since both the degree of altitude and total hours of exposure must be taken into account (49) . Further, Gore et al. (23) predict that 97.5% of athletes will increase Hbmass by 1-5% after 240 h.
In the second half of the race, the riders left the high mountains behind, not sleeping higher than ϳ1,500 m. With a diminished hypoxic stimulus, a slight decrease in Hbmass was observed between the midrace and final measurement time points. While this may be due to measurement error and random variation (23) , another possible explanation lies in the physiological phenomenon of neocytolysis; the selective destruction of young red blood cells known as neocytes, which occurs when changing environmental conditions deem the cells to be "in excess" (2) . The phenomenon first observed in space flight (3) has also been reported in newborn infants and in low-altitude dwellers following an altitude sojourn (36) . Since the Hbmass response measured midrace occurred rapidly, it could be assumed that the majority of these new red blood cells were vulnerable and at risk of destruction by neocytolysis. Once the race descended to low altitude, the likely ensuing suppression of erythropoietin and increased arterial oxygen saturation may have determined that extra red cell mass was no longer required.
The observed changes in reticulocyte values also depict a similar scenario, with absolute and relative reticulocytes increasing during the first half of the race before decreasing in the latter stages and appearing somewhat suppressed. Reticulocyte percentage is a parameter of interest to antidoping authorities and is used in many indirect doping detection models (including the Athlete Biological Passport) since they display distinctive characteristics in response to the use of several doping methods. Reticulocyte suppression in response to synthetic erythropoietin withdrawal forms the basis of the currently used "off model" (22) . During prolonged altitude exposure, serum erythropoietin concentration typically peaks within 24 -48 h before decreasing to near baseline values for the remainder of exposure (14) . When the altitude stimulus is removed, serum erythropoietin concentration may decrease further since the drive for accelerated erythropoiesis is no longer necessary. While serum erythropoietin data were not available, it could be postulated that serum erythropoietin concentrations would likely decrease during the latter stages of the tour, when racing was conducted at much lower altitudes. Unfortunately, we were not able to measure ferritin or haptoglobin during the tour, both of which could have shed further light on the processes behind the observed changes in Hbmass. Recently, Corsetti et al. (9) reported an increase in haptoglobin during a 3-wk "grand tour," which was moderately correlated to the inflammatory marker C-reactive protein (CRP) and inversely correlated to the decrease in [Hb] . However, ferritin values remained stable and did not show an increase in support of hemolysis (36) . Furthermore, in the original article, PV changes were erroneously calculated, as highlighted by Gore et al. (21) , and later corrected to show an increase (29) in accordance with previous research (12, 32, 33, 40) , indicating that hemolysis was an unlikely explanation for the decrease in [Hb] .
Wellness and hydration. The observed changes in body mass, resting heart rate, oxygen saturation, and hydration status of the sea-level residents during the race reflect the changing physiological and environmental demands of the stage race (Table 4 ). Resting heart rate was highest and oxygen saturation lowest following the nights spent at the higher altitudes (Ͼ3,000 m), and these coincided with poorer wellbeing and higher Lake Louise scores. While the Lake Louise Questionnaire was designed as a tool to diagnose acute mountain sickness (AMS), it may have limited application in the current setting since high scores, which could potentially indicate mild or even severe AMS can be achieved if the patient experiences gastrointestinal upset, poor sleep, dehydration, or fatigue (25) . It is not uncommon for athletes to report such complaints during cycling stage racing, particularly in foreign environments, but in the majority of cases reported in the current data set, such symptoms were reported in the absence of headache and thus failed to meet the criteria for diagnosis of AMS (37) .
The stability of body mass and hydration status of the sea-level residents for the majority of the tour provides further support for the veracity of the PV expansion. A decrease in body mass associated with decreased water loss and dehydration would serve to blunt or mask any PV expansion. Conversely, any water retention or peripheral edema associated with mild altitude sickness may have exacerbated the PV response. However, a relatively uniform response of both [Hb] and PV was observed in the majority of athletes throughout the tour (Fig. 1) ; thus any individual variation in altitude symptoms is deemed unlikely to have confounded our results.
Applications for altitude training. Our findings may also have potential implications for altitude training. In previous studies, so called "responders" and "nonresponders" have been identified based on their response to altitude training in terms of both hematological adaptation and performance (28) . Some have suggested that such responses are linked to individual genetic disposition (18) , while others suggest that the response to altitude training is tied to the right stimulus (49) and that failure to adapt might be caused by overreaching (19) or other medical conditions (17) . Our data indicate that despite the very heavy workload during racing, in addition to some reports of increasing life stress and potential mild illness, hematological adaptations were still present in sea-level residents. Such a response may be attributable to the particular attention to overall well-being and recovery "off the bike" (e.g., nutrition, massage, and hydration), which accompanies a stage race of such nature. The lasting implications of this type of workload at altitude for sea-level performance, however, remain to be elucidated and fall outside the scope of this investigation.
Limitations. Since the data presented in this study were obtained in a real race situation, and at times in remote and challenging environments, a balance was required between the ideal number of measurements and the logistics required around each measurement while all the while attempting to be as minimally invasive or disruptive to competing athletes. Indeed, direct measurement of PV is preferential to calculated values where possible (26), but was not possible during a field-based study of this nature. In addition, while four teams were initially targeted for the study, complete data sets were only available for ϳ60% of the cohort due to rider withdrawals associated with illness (n ϭ 1), injury (n ϭ 2), or failure to finish a stage within the time limit (n ϭ 3). Thus, when interpreting our results, the field-based nature of our study (and subsequent inability to control some aspects of the study design) should be considered. Similarly, the global distribution and variation of professional cycling races may make direct comparison of our results against other events somewhat difficult.
Summary
Multiday cycle racing at altitude induces hemodilution in altitude residents due to PV expansion. Similarly, hemodilution occurs in nonacclimatized sea-level residents, despite an altitude induced increase in Hbmass. Osmotic regulatory mechanisms associated with intense exercise appear to supersede acute enhancement of oxygen delivery at altitude.
